medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2007, Number 2

<< Back Next >>

Rev Mex Patol Clin Med Lab 2007; 54 (2)

N. meningitidis. A case report of meningitis complicated with septic arthritis

Sevilla E, Ramírez RJM, Villarreal HL, Mata E, Trujillo LJ

Language: Spanish
References: 29
Page: 83-91
PDF size: 153.78 Kb.


ABSTRACT

Meningococcal meningitis is a disease that can be originated by different serogroups of N. meningitidis. The transmission is by contact through nasal secretions. Epidemiologic is under monitoring and is of immediate notification. In center National Medical of the West was taken care of feminine patient of 20 years of age, previously treated in first level of attention to present a compatible clinic with meningococcal meningitis. The diagnosis was made through friction and Gram stain of cephalorachidean liquid (LCR): Gram negative Diplococcus and through coagglutination of LCR determined positive for N. meningitidis of group A. The cultive was negative 72 hours of incubation possibly by to have received treatment antimicrobial, previous to its hospitalization. When she was in hospital, presented ankle´s arthritis, with negative study microbiologic of the liquid sinovial. The characteristic clinico/epidemiologics of the case are shown as well as the actions generated by their identification.


REFERENCES

  1. CDC. Division of AIDS, STD, and TB Laboratory Research. N. meningitidis. URL: http://www.cdc.gov/ncidod/dastlr/gcdir/NeIdent/Nmen.html

  2. Real RB. Programa de vacunación frente a la enfermedad meningocócica por serogrupo C: situación epidemiológica y utilización de la vacuna conjugada como instrumento de control. Rev Pediatr Aten Primaria 2000; 2 (8): 121-156.

  3. Pollard AJ, Moxon ER. Archives of disease in childhood H ¿El meningococo domado? Oxford, Reino Unido: Oxford Vaccine Group, Departamento de Pediatría. Universidad de Oxford, John Radcliffe Hospital, 1021.

  4. Ministerio de Salud de Nicaragua. Boletín Epidemiológico 2004; Semana 07 del 15 al 21 de febrero.

  5. González A, Franco C, Pérez L, Santos I. Enfermedad por meningococo, Neisseria meningitidis: Perspectiva epidemiológica, clínica y preventiva. Rev Salud Pública Mex 2004; 46: 438-450.

  6. C.D.C. Laboratory Methods for the Diagnosis of Meningitis caused by Neisseria meningitidis, Streptococcus, pneumoniae, and Haemophilus influenzae. 1998: 1-95.

  7. Control and prevention of meningococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Source: MMWR, February 14, 1997; 46 (RR-05): 1-51. www.cdc.gov/mmwr/preview/mmwrhtml/00046263.htm

  8. Fonkoua MC, Taha MK, Pierre N, Cunin P, Alonso JM, Bercion R et al. Recent increase in meningitis caused by Neisseria meningitidis serogroups A and W135, Yaoundé, Cameroon. Emerg Infect Dis 2002; 8 (3). CDC.

  9. www.ssa.gob.mx (Distribución de los casos nuevos de enfermedad por grupos de edad. Sistema Nacional de Salud) Estados Unidos Mexicanos. Anuarios de Morbilidad de la Dirección General de Epidemiología. Secretaría de Salud 1990-2005.

  10. Rivadeneira S, Aguad L, Bencini Rossana, Palomino C. Meningitis meningocócica: Estudio Clínico de 134 casos; 1978-1988. Rev Chil Infectol 1989; 6 (2): 76-81.

  11. Enfermedad meningocócica (Meningitis meningocócica/meningococcemia) (CIE-10 A39).

  12. Instituto Nacional de Salud. Ministerio de Salud. Subdirección de Epidemiología y Laboratorio Nacional de Referencia. Programa Nacional de Vigilancia y Control de Infecciones Respiratorias y Meningitis Agudas. Meningitis Bacterianas. Importancia Epidemiológica del Evento.

  13. Yung AP, McDonald MI. Early clinical clues to meningococcemia. Med J Aust 2003; 178 (3): 134-137.

  14. Allan R, Tunkel W, Scheld M. Acute meningitis. In: Mandell D, Bennett´s. Principles and practice of infectious diseases. 4th edition. EUA: Elsevier; 1995: 831-864.

  15. Johns Hopkins University, Division of Infectious Diseases. Antibiotic Guide v 2.0. www.hopkins-abxguide.org

  16. Hui L, Tokeshi J. Dexamethasone use in adult meningococcal meningitis. Hawaii Med J 2000; 59 (7): 308-309.

  17. McIntyre P. Should dexamethasone be parto of routine therapy of bacterial meningitis in industrialized countries? Adv Exp Med Biol 2005; 568: 189-197.

  18. Lauritsen A, Oberg B. Adjunctive corticosteroid therapy in bacterial meningitis. Scand J Infect Dis 1995; 25 (5): 431-434.

  19. Thomas R, Le Tulzo Y, Bouget J, Camus C, Michelet C, Le Corre P, Bellissant E. Trial of dexamethasone treatment for severe bacterial meningitis in adults. Adult Meningitis Steroid Group. Intensive Care Med 1999; 25 (5): 475-480.

  20. Barquet N, Domingo P, Cayla JA, Gonzalez J, Rodrigo C, Fernandez-Viladrich P et al. Meningococcal disease in a large urban population (Barcelona, 1987-1992): Predictors of Dismal Prognosis. Barcelona Meningococcal Disease Surveillance Group. Arch Intern Med 1999; 159 (19): 2329-2340.

  21. Chin J. II. A. Infección meningocócica CIE-9 136; CIE-10 A39. En: El control de las enfermedades transmisibles. 17ª edición. Washington D.C: Organización Panamericana de la Salud; 2001: 427-433.

  22. Gardner P. Prevention of meningococcal disease. N Engl J M 2006; 355: 1466-1473.

  23. Vienne P, Ducos-Galand M, Guiyoule A, Pires R, Giorgini D, Taha MK et al. The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia. Clin Infect Dis 2003; 37 (12): 1639-1642.

  24. Vikram HR, Buencamino RB, Aronin SI. Primary meningococcal arthritis in a prosthetic knee joint. J Infect 2001; 42 (4): 279-281.

  25. Cartolano GL, Le Lostec Z, Cheron M, Boisivon A, Welker Y, Mornet P. Primary Neisseria meningitidis arthritis of the knee without meningitis: contribution of synovial fluid culture in blood-culture vial. Rev Med Interne 2001; 22 (1): 75-78.

  26. Christensen C. Meningococcal infection and arthritis. Ugeskr Laeger 1990; 152 (19): 1357-1359.

  27. Quintana JI, Muñiz AM. El papel del médico de la familia en el control de los síndromes neurológicos infecciosos. Rev Cubana Med Gen Integr 1999; 15 (6): 636-640.

  28. Escobar VJ. Application of epidemiologic surveillance polices: Meningococcal meningitis in cancers. Bol Epidemiol Antioq 1986; 11 (4): 196-198.

  29. Arias VM, Arango GC, Alvarez IC, Ceballos LE. Learning experience during the practice of epidemiologic surveillance of one transmissible disease: Meningococcal meningitis invest. Educ Enferm 1989; 7 (2): 11-25.




2020     |     www.medigraphic.com